New therapeutic strategies to treat leishmaniasis.
8-HQN was tested against promastigotes and amastigotes of three Leishmania species.
It presented better in vitro results in comparison to amphotericin B.
8-HQN causes alterations in the Leishmania mitochondrial membrane potential.
It was able to reduce the lesion diameter and parasite load in BALB/c mice.